XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenues
Our disaggregated revenues were as follows (in thousands):
Three Months Ended
 September 30,
Nine Months Ended
September 30,
2023202220232022
Royalties$114,433 $99,551 $325,813 $254,496 
Product sales, net
  Sales of bulk rHuPH2037,001 19,259 86,203 60,764 
Sale of proprietary products31,511 24,180 91,765 44,559 
Sale of device partnered products18,057 17,988 43,284 24,544 
Total product sales, net$86,569 $61,427 $221,252 $129,867 
Revenues under collaborative agreements
  Upfront license and target nomination fees— — — 30,000 
  Event-based development and regulatory milestone and other fees13,000 44,000 46,000 59,000 
  Device licensing and development revenue2,031 3,998 6,149 5,257 
Total revenues under collaborative agreements$15,031 $47,998 $52,149 $94,257 
Total revenues$216,033 $208,976 $599,214 $478,620 
Schedule of accounts receivable, deferred revenues from contracts with customers, and amounts under collaborative agreements included in transaction price
Accounts receivable, other contract assets and deferred revenues (contract liabilities) from contracts with customers, including partners, consisted of the following (in thousands):
September 30, 2023December 31, 2022
Accounts receivable, net$213,987 $186,970 
Other contract assets3,338 44,102 
Deferred revenues2,920 5,499